Answers are grounded in this paper and cite their sources.
ATS7vac is a novel atherosclerosis vaccine that also alleviates in-stent restenosis. The application of ATS7vac would be a complementary therapeutic avenue to the current lipid-lowering strategy for atherosclerotic disease.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: